维普期刊资源整合服务平台（V6.5）

117篇 您的检索式：作者名="Channick"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension显示文摘	Khanna D Gladue H Channick R	2013	Arthritis Rheum2013，65，12：	1
2	Updated Clinical Classification of Pulmonary Hypertension显示文摘	Gérald Simonneau Ivan M. Robbins Maurice Beghetti Richard N. Channick Marion Delcroix Christopher P. Denton C. Gregory Elliott Sean P. Gaine Mark T. Gladwin Zhi-Cheng Jing Michael J. Krowka David Langleben Norifumi Nakanishi Rogério Souza	2009	Journal of the American College of Cardiology2009，，1：	1
3	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension:a randomized placebo-controlled study显示文摘	Channick R N Simonneau G Sitbon O	2001	Lancet2001，358，9287：	1
4	Hyperthyroidism and mitral-valve prolapse 显示文摘	CHANNICK B J	1981	NewEngl J Med1981，305，9：	1
5	Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension显示文摘	Channick RN Olschewski H Seeger W	2006	J Am Coll Cardiol2006，48，：	1
6	Endothelin antagonism in pulmonary arterial hypertension显示文摘	Lee SH Channick RN	2005	Semin Respir Crit Care Med2005，26，4：	1
7	Endothelin receptor antagonists in pulmonary arterial hypertension显示文摘	Channick RN Sitbon O Barst RJ	2004	J Am Coll Cardiol2004，43，：	1
8	Inhaled nitric oxide as a screening agent for safety identifying responders to oral calcium-channel blockers in primary pulmonary hypertension显示文摘	Sitbon O Badech DB Channick RN	1998	Eur Respir J1998，12，：	1
9	Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension:a 1-year follow up study显示文摘	Sitbon O Badesch DB Channick RN	2003	Chest2003，124，1：	1
10	Effects of the dual en- do-thelin-receptor antagonist bosentan in patients with pulmonary hy- pert-ension: a random-ised placebo controlled study 显示文摘	Channick RN Simonneau G Sitbon O	2001	Lancet2001，358，9288：	1
11	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study 显示文摘	Simonneau G Sitbon O	2001	Lancet2001，358，9288：	1
12	Diagnosis, as-sessment ,and treatment of non - pulmonary arterial hypertensionpulmonary hypertension显示文摘	Hoeper MM Barbera JA Channick RN	2009	J Am Coll Cardiol2009，54，1：	1
13	Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterialhypertension:a 1-year follow up study显示文摘	Sitbon O Badesch DB Channick RN		0，，：	1
14	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension:a randomised placebocontrolled study显示文摘	Channick RN Simonneau G Sitbon O	2001	Lancet2001，358，9288：	1
15	Maciten- tan and morbidity and mortality in pulmonary arterial hyper- tension显示文摘	PULIDO T ADZERIKHO I CHANNICK R N	2013	N Engl J Med2013，369，：	1
16	Orvnic 3hroml~etrt~c Pulrmnmy Hytx~ension: the End Result of Pulmonary Embolism 显示文摘	Witldn AS Channick RN	2015	Curt Cardiol Rep2015，17，8：	1
17	Macitentan and morbidity and mortality in pulmonary arterial hypertension显示文摘	Pulido T Adzerikho I Channick RN	2013	N Engl J Med2013，369，9：	1
18	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study 显示文摘	Channick RN Simonneau G Sitbon O	2001	Lancet2001，358，：	1
19	Surgical treatments/interventions for pulmonary arterial hypertension:ACCP evidence-based clinical practice guidelines显示文摘	Doyle RL McCrory D Channick RN	2004	Chest2004，126，1：	1
20	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonaryhy pertension:a randomised placebo-controlled study显示文摘	Channick RN。Simonneau G。Sitbon et a1	2001	Lancet2001，358，9288：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示